Piet M Ter Wee
Overview
Explore the profile of Piet M Ter Wee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heijsters F, van Breda F, van Nassau F, van der Steen M, Ter Wee P, Mullender M, et al.
BMC Health Serv Res
. 2022 Apr;
22(1):550.
PMID: 35468765
Background: The emphasis on implementation of value-based healthcare (VBHC) has increased in the Dutch healthcare system. Yet, the translation of the theoretical principles of VBHC towards actual implementation in daily...
2.
de Roij van Zuijdewijn C, van Gastel L, Ter Wee P, Bots M, Blankestijn P, van den Dorpel M, et al.
Clin Kidney J
. 2021 Feb;
14(1):375-381.
PMID: 33564441
Background: C-type natriuretic peptide (CNP) and its co-product N-terminal proCNP (NTproCNP) have been associated with beneficial effects on the cardiovascular system. In prevalent dialysis patients, however, a relation between NTproCNP...
3.
Tonneijck L, Smits M, Muskiet M, Hoekstra T, Kramer M, Danser A, et al.
Diabetes Care
. 2019 Jan;
42(3):494.
PMID: 30674545
No abstract available.
4.
Adema A, de Roij van Zuijdewijn C, Hoenderop J, de Borst M, Ter Wee P, Heijboer A, et al.
BMC Nephrol
. 2018 Nov;
19(1):327.
PMID: 30442108
Background: The CKD-associated decline in soluble α-Klotho (α-Klotho) levels is considered detrimental. Some studies suggest a direct induction of α-Klotho concentrations by growth hormone (GH). In the present study, the...
5.
Nube M, Hoekstra T, Doganer V, Bots M, Blankestijn P, van den Dorpel M, et al.
Hemodial Int
. 2018 Feb;
22(3):359-368.
PMID: 29461006
Introduction: While concentric left ventricular hypertrophy (cLVH) predominates in non-dialysis-dependent chronic kidney disease (CKD), eccentric left ventricular hypertrophy (eLVH) is most prevalent in dialysis-dependent CKD stage 5 (CKD5D). In these...
6.
Verkaik M, van Poelgeest E, Kwekkeboom R, Ter Wee P, van den Brom C, Vervloet M, et al.
Am J Physiol Heart Circ Physiol
. 2017 Nov;
314(3):H381-H391.
PMID: 29101165
Myocardial contrast echocardiography (MCE) offers the opportunity to study myocardial perfusion defects in mice in detail. The value of MCE compared with single-photon emission computed tomography, positron emission tomography, and...
7.
Loon I, Hamaker M, Boereboom F, Grooteman M, Blankestijn P, van den Dorpel R, et al.
Age Ageing
. 2017 Mar;
47(2):320.
PMID: 28338938
No abstract available.
8.
Loon I, Hamaker M, Boereboom F, Grooteman M, Blankestijn P, van den Dorpel R, et al.
Age Ageing
. 2017 Feb;
46(4):594-599.
PMID: 28164208
Background: in chronic hemodialysis, physical functioning (PF) is known to be poor. We set out to assess to what extent chronic dialysis patients are able to maintain a good physical...
9.
van Rodijnen W, van Lambalgen T, van Teijlingen M, Tangelder G, Ter Wee P
J Renin Angiotensin Aldosterone Syst
. 2017 Jan;
2(1_suppl):S204-S210.
PMID: 28095224
Angiotensin II (Ang II) type 1 (AT1) receptor blockers differ in their affinity for the AT1-receptor, suggesting a dissimilar potency for inhibiting Ang II-induced vascular constriction. In the present study,...
10.
Tonneijck L, Smits M, Muskiet M, Hoekstra T, Kramer M, Danser A, et al.
Diabetes Care
. 2016 Sep;
39(11):2042-2050.
PMID: 27585605
Objective: To investigate effects of dipeptidyl peptidase-4 inhibitor (DPP-4I) sitagliptin or glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide treatment on renal hemodynamics, tubular functions, and markers of renal damage in...